In market activity today, Hls Therapeutics Inc shares closed at $4.89 after opening the day at $4.94. It traded at a low of $4.89 to a high of $5.01.

The price decreased -1.01 percent from the previous day's close of $4.94.

During the day across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 5,800 shares was traded during the last trading day, with total trades of 15, while having an average volume of 10,369 over the last 5-days.

The TSX market on the whole today saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have tumbled -20.23%, while this year, they have raised 23.80%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $157.52 million on a float of 31,921 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..